Castle Biosciences, Inc. (CSTL) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Castle Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.617 -- 00:00:06.583 Good afternoon and welcome to Castle Biosciences' fourth quarter and full year 2025 conference 00:00:06.583 -- 00:00:10.048 call. As a reminder, today's call is being recorded. 00:00:10.048 -- 00:00:13.872 We will begin today's call with opening remarks and introductions, followed by a question 00:00:13.872 -- 00:00:18.518 and answer session. I would like to turn the call over to Camilla Sequeira, Vice President, 00:00:18.518 -- 00:00:21.840 Investor Relations and Corporate Affairs. 00:00:23.785 -- 00:00:26.626 Thank you, Operator. Good afternoon, everyone. 00:00:26.626 -- 00:00:31.652 Welcome to Castle Bioscience's fourth quarter and full year 2025 results conference 00:00:31.652 -- 00:00:36.677 call. Joining me today are Castle's founder, president, and chief executive officer, 00:00:36.677 -- 00:00:40.822 Derek Matfield, and chief financial officer, Frank Stokes. 00:00:40.822 -- 00:00:45.687 Information recorded on this call speaks only as of today, February 26, 2026. 00:00:45.687 -- 00:00:47.369 Therefore, 00:00:47.369 -- 00:00:52.515 if you are listening to the replay or reading the transcript of this call, any time sensitive 00:00:52.515 -- 00:00:57.309 information may no longer be accurate. A recording of today's call will be available 00:00:57.309 -- 00:01:01.996 on the investor relations page of the company's website for approximately three weeks 00:01:01.996 -- 00:01:05.001 following the conclusion of the call. 00:01:05.001 -- 00:01:08.547 Before we begin, I would like to remind you that some of the statements made today will 00:01:08.547 -- 00:01:13.556 contain forward-looking statements, including statements about expected addressable markets, 00:01:13.556 -- 00:01:18.664 statements containing projections regarding futu...